Literature DB >> 15951802

Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis.

Yong Zhao1, Eva Samal, Deepak Srivastava.   

Abstract

Gradients of signalling and transcription factors govern many aspects of embryogenesis, highlighting the need for spatiotemporal control of regulatory protein levels. MicroRNAs are phylogenetically conserved small RNAs that regulate the translation of target messenger RNAs, providing a mechanism for protein dose regulation. Here we show that microRNA-1-1 (miR-1-1) and miR-1-2 are specifically expressed in cardiac and skeletal muscle precursor cells. We found that the miR-1 genes are direct transcriptional targets of muscle differentiation regulators including serum response factor, MyoD and Mef2. Correspondingly, excess miR-1 in the developing heart leads to a decreased pool of proliferating ventricular cardiomyocytes. Using a new algorithm for microRNA target identification that incorporates features of RNA structure and target accessibility, we show that Hand2, a transcription factor that promotes ventricular cardiomyocyte expansion, is a target of miR-1. This work suggests that miR-1 genes titrate the effects of critical cardiac regulatory proteins to control the balance between differentiation and proliferation during cardiogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15951802     DOI: 10.1038/nature03817

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  656 in total

Review 1.  Small RNAs have a big impact on regeneration.

Authors:  Elizabeth J Thatcher; James G Patton
Journal:  RNA Biol       Date:  2010-05-14       Impact factor: 4.652

Review 2.  Advances in exploring the role of microRNAs in the pathogenesis, diagnosis and therapy of cardiac diseases in China.

Authors:  Z W Pan; Y J Lu; B F Yang
Journal:  Br J Pharmacol       Date:  2015-01-20       Impact factor: 8.739

3.  MicroRNA-214 promotes myogenic differentiation by facilitating exit from mitosis via down-regulation of proto-oncogene N-ras.

Authors:  Jun Liu; Xiao-Ju Luo; An-Wen Xiong; Zeng-di Zhang; Shen Yue; Ming-Sheng Zhu; Steven Y Cheng
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

4.  Determination of miRNA targets in skeletal muscle cells.

Authors:  Zhan-Peng Huang; Ramón Espinoza-Lewis; Da-Zhi Wang
Journal:  Methods Mol Biol       Date:  2012

5.  MicroRNAs: Novel Regulators of the Heart.

Authors:  Junjie Xiao; Yi-Han Chen
Journal:  J Thorac Dis       Date:  2010-03       Impact factor: 2.895

6.  L-Sox5 and Sox6 proteins enhance chondrogenic miR-140 microRNA expression by strengthening dimeric Sox9 activity.

Authors:  Satoshi Yamashita; Shigeru Miyaki; Yoshio Kato; Shigetoshi Yokoyama; Tempei Sato; Francisco Barrionuevo; Haruhiko Akiyama; Gerd Scherer; Shuji Takada; Hiroshi Asahara
Journal:  J Biol Chem       Date:  2012-04-30       Impact factor: 5.157

7.  Mir-24 regulates hepatocyte apoptosis via BIM during acute liver failure.

Authors:  Zhiwen Feng; Zhi Li; Deming Zhu; Wei Ling; Lei Zheng; Liyong Pu; Lianbao Kong
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

8.  Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells.

Authors:  Yun Lu; J Michael Thomson; Ho Yuen Frank Wong; Scott M Hammond; Brigid L M Hogan
Journal:  Dev Biol       Date:  2007-08-09       Impact factor: 3.582

9.  MicroRNA-regulated pathways associated with endometriosis.

Authors:  E Maria C Ohlsson Teague; Kylie H Van der Hoek; Mark B Van der Hoek; Naomi Perry; Prabhath Wagaarachchi; Sarah A Robertson; Cristin G Print; Louise M Hull
Journal:  Mol Endocrinol       Date:  2008-12-12

Review 10.  MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine.

Authors:  V Sala; S Bergerone; S Gatti; S Gallo; A Ponzetto; C Ponzetto; T Crepaldi
Journal:  Cell Mol Life Sci       Date:  2013-11-12       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.